Sharing Progress in Cancer Care

Startseite
Schweiz
Bellinzona
Sharing Progress in Cancer Care

SPCC is a non-profit association, based in Switzerland, working in the field of cancer education.

28/08/2026

How can we effectively translate emerging biomarker evidence into daily multidisciplinary decisions for breast cancer care?

We are delighted to announce the launch of the new online course for the Definitive Trial Project, "Precision Oncology in HER2-Positive Breast Cancer: From Biomarkers to Personalised Care", broadcasting live on 📆 Monday, 28 September 2026, from 12:00 to 15:00 CEST.

Chaired by Matti Aapro and Seamus O’Reilly, this interactive three-hour session gathers an outstanding international faculty, including Paola Clauser, Marta González, Monika Gräser, Gaia Griguolo, Esther Sanfeliu Torres, and Francesco Schettini.

Together, they will explore the full continuum of care, from precision imaging and diagnostic biomarkers to treatment escalation, de-escalation strategies, and the clinical integration of tools like HER2DX®.

Participation is free of charge, but registration is mandatory.
👉 Secure your place on OncoCorner: https://www.oncocorner.net/index.php?p=events&id=C-55

Funded by the European Union – Horizon Europe Grant Agreement No. 101136953.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.
This work has also received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).

06/08/2026

Are you looking to bridge the gap between clinical evidence and real-world patient expectations in supportive cancer care?

The on-demand recording of our recent symposium at the MASCC/ISOO 2026 Annual Meeting, "Improving outcomes in MEC: clinical evidence, trial insights and the patient perspective", is now available free of charge on OncoCorner.

Chaired by Matti Aapro and Florian Scotté, this session dives into the persistent challenges and unmet needs in managing moderate emetogenic chemotherapy (MEC). Featuring critical insights from Mario Di Palma on current treatment landscapes, Matti Aapro on trial data for risk assessment, and Eva Schumacher-Wulf on the patient voice, the discussion delivers essential guidance for healthcare professionals, researchers, and patient advocates alike.

👉 Watch the full session on-demand: https://www.oncocorner.net/index.php?p=events&id=A-535

Multinational Association of Supportive Care in Cancer - MASCC

28/07/2026

OncoCorner is SPCC’s digital space where perspectives, insights, and forward-looking developments across the cancer care continuum come together.

A place shaped by our mission to connect stakeholders committed to meaningful innovation and to improving outcomes for every patient, everywhere.

It is made possible thanks to the continuous commitment of the companies part of the Sustaining Corporate Programme. We would also like to acknowledge the unconditional support of Astrazeneca S.p.A.

Explore more: www.oncocorner.net/

10/07/2026

How can artificial intelligence move from a technological trend to an active driver of clinical decisions?

Artificial intelligence is increasingly embedded across all stages of cancer care, offering transformative opportunities to enhance diagnostic accuracy, optimise workflows, and support therapeutic choices.

📆 To explore this evolution, join us on Tuesday 29 September 2026, from 18:00 to 19:00 CEST, for our live webinar "Explore how AI is reshaping oncology, from foundational concepts to future applications".

Led by Pietro Presti, the session features insights from Aleksandra Filipovic on the contributions of AI to precision oncology, and Rebecca Romanò on current applications and future perspectives. The presentations will be followed by an interactive Q&A session to address your questions.

Participation is free of charge, but registration is mandatory.
👉 Secure your place here: https://www.oncocorner.net/index.php?p=events&id=A-533

This session is part of the SPCC Sustaining Corporate Programme 2026.
Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.

30/06/2026

OncoCorner brings SPCC’s work into one space to foster dialogue, and support innovation across prevention, diagnosis, treatment, and integrative care.

A digital hub driven by our commitment to equity, personalisation, and better outcomes for all.

It is made possible thanks to the continuous commitment of the companies part of the Sustaining Corporate Programme. We would also like to acknowledge the unconditional support of Astrazeneca S.p.A.

Discover OncoCorner: www.oncocorner.net/

29/06/2026

As we prepare to enter the next phase of our Minimal Residual Disease (MRD) educational project, now is the perfect time to catch up on the foundational discussions that brought us here.

Our first two project webinars are available completely on-demand, offering deep insights into the evolving landscape of MRD testing in Multiple Myeloma.

📌 On 2 July 2026, SPCC will convene a closed virtual Task Force bringing together a distinguished panel of international experts, led by our Moderator Dr Matti Aapro and an exceptional Advisory and Leadership Team including sikander ailawadhi, Carl Ola Landgren, Bruno Paiva, and Jesús San-Miguel.

The Task Force will tackle critical challenges in the field, moving from whether MRD is ready for routine decision-making to closing the gap between guidelines and daily real-world practice.

The experts will also address how to make laboratory results truly actionable for clinicians and explore the future of blood-based monitoring and adaptive trials.

All the key outcomes, practical highlights, and considerations emerging from this high-level meeting will be consolidated into an upcoming white paper, designed to provide a balanced, practice-oriented overview of current evidence.

👉 Learn more and watch the on-demand webinars: https://www.spcc.net/events-and-activities/other-activities/educational-project-on-minimal-residual-disease-mrd-in-multiple-myeloma-2026/

This activity is supported by: an independent grant from Cloud Pathology Group and by an unrestricted medical contribution from Sanofi (Phase 1); by an unrestricted medical contribution from Sanofi, with procedures ongoing for the finalisation of further independent support from a second company (Phase 2).

25/06/2026

Today in Melbourne, Australia, SPCC successfully hosted the live, in-person symposium "Improving outcomes in MEC: clinical evidence, trial insights and the patient perspective", held during the opening day of the MASCC/ISOO 2026 Annual Meeting.

Multinational Association of Supportive Care in Cancer - MASCC

The session brought together leading international experts to explore the current landscape and address the persistent unmet needs in the management of MEC.

The faculty engaged a diverse, multidisciplinary audience of clinicians, nurses, researchers, and patient advocates by sharing crucial insights from recent clinical trials on risk assessment, while also shining a spotlight on the patient experience through real-world perspectives.

A warm thank you to our expert speakers Matti Aapro, Mario Di Palma, Eva Schumacher-Wulf, and florian Scotté, as well as to everyone who attended and contributed to these vital discussions.

For those who could not join us live in Australia, the full symposium recording and related educational materials will soon be made available on-demand via OncoCorner, SPCC’s e-learning platform (www.oncocorner.net/).

This educational activity is supported by an unrestricted educational grant from Helsinn Healthcare SA and is organised by SPCC.

09/06/2026

Highlights from yesterday’s Task Force on Oncology Nutrition Integration

Yesterday, 8 June, SPCC brought together a distinguished panel of international experts for the Oncology Nutrition Integration Task Force. Malnutrition remains a significant challenge across the oncology care continuum, heavily impacting treatment outcomes and patient quality of life.

To bridge the gap between evidence and routine clinical practice, our Faculty engaged in high-level discussions to drive a more coordinated, multidisciplinary approach.

During the meeting, the experts focused on clarifying multidisciplinary team roles for oncologists, nurses, pharmacists, and social workers, whilst also developing new frameworks to better integrate patient bodies.

The discussions also provided crucial guidance on the transition from hospital to home care and explored the potential of digital apps for personalised nutrition tracking.

The insights and recommendations emerging from yesterday’s closed meeting will now be consolidated into a comprehensive manuscript to support healthcare professionals worldwide.

A special thanks to our Moderator, Prof. Matti Aapro, our Chair, Prof. Eric Van Cutsem, and all the incredible experts who contributed to this vital initiative.

This educational project is developed in collaboration with Fresenius Kabi.

01/06/2026

SPCC is organising a live, in-person symposium, which took place during the MASCC/ISOO 2026 Annual Meeting in Melbourne, Australia (June 25-27, 2026).

🔬 This symposium will convene leading experts to explore the current landscape and unmet needs in management, discuss insights from recent clinical trials on risk assessment, and highlight the patient experience through real-world perspectives.

The session aims to address persistent gaps in current practice by offering updated, evidence-based insights.

The symposium recording and the related on-demand materials will be made available via OncoCorner.

👉🏼 Learn more: https://www.spcc.net/events-and-activities/onsite-events/?id=121633

This educational activity is supported by an unrestricted educational grant from Helsinn Healthcare SA and is organised by SPCC.

Multinational Association of Supportive Care in Cancer - MASCC

28/05/2026

How can we translate complex tumour biology into everyday clinical care?

Join us for the sixth session of the Definitive Trial Project, a European Commission-funded clinical trial demonstrating how the HER2DX® diagnostic assay can personalise treatment decisions and improve quality of life for patients with early-stage HER2-positive breast cancer, without compromising outcomes.

Programme:
HER2DX: biological bases – Francesco Schettini (ES)
HER2DX: clinical perspective – Marta González (ES)
Discussion and Q&A – Moderated by Aleix Prat (ES)

Access is free of charge, but registration is mandatory.

👉 Register here: https://www.oncocorner.net/index.php?p=events&id=A-528

Funded by the European Union – Horizon Europe Grant Agreement No. 101136953.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.
This work has also received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).

Adresse

Via Vincenzo Vela 6
Bellinzona
6500

Telefon

+41918200968

Webseite

http://www.spcc.net/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Sharing Progress in Cancer Care erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.